Atrial fibrillation and stroke prevention: where we are and where we should be
- PMID: 29853572
- PMCID: PMC6001982
- DOI: 10.3399/bjgp18X696257
Atrial fibrillation and stroke prevention: where we are and where we should be
Erratum in
-
Corrections.Br J Gen Pract. 2018 Aug;68(673):367. doi: 10.3399/bjgp18X698309. Br J Gen Pract. 2018. PMID: 30049761 Free PMC article. No abstract available.
References
-
- Evans T. Atrial fibrillation prevalence estimates in England: application of recent population estimates of AF in Sweden. Public Health England; 2017. https://www.gov.uk/government/uploads/system/uploads/attachment_data/fil... (accessed 4 May 2018).
-
- National Institute for Health and Care Excellence Atrial fibrillation: management CG180. 2014. https://www.nice.org.uk/guidance/CG180 (accessed 8 May 2018). - PubMed
-
- Mant J, Hobbs FD, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet. 2007;370(9586):493–503. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical